AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Download the new Monitorian 4.4.21/26/2024 Such factors impacted market growth positively during the pandemic. The Mediray technical support line remained open for call-in and pick-up options. Mediray (Distributor Company for Freestyle Libre Products) was classed as an essential service and continued to provide FreeStyle Libre systems as usual. These groups were especially vulnerable to the far-reaching impacts of the COVID-19 crisis, as they were disproportionately exposed to risk, potentially exacerbated by the sudden loss of jobs and income, and reduced access to usual social support and healthcare. Notably, the rates of diabetes are higher among Maori, Pacific, and South Asians compared with New Zealand Europeans, particularly those living in deprived situations. All necessary steps were taken and maintained to protect this high-risk group through nationwide public health measures to prevent transmission, ensuring vaccination has been given and undertaking workplace risk assessments. ![]() ![]() The COVID-19 pandemic highlighted that substantially greater attention had to be given to diabetes to avoid unnecessary and inequitable outcomes from the infection. The New Zealand Continuous Glucose Monitoring Devices Market size is estimated at NZD 44.82 million in 2023, and is expected to reach NZD 84.79 million by 2028, growing at a CAGR of 13.60% during the forecast period (2023-2028). New Zealand Continuous Glucose Monitoring Devices Market Analysis
0 Comments
Read More
Leave a Reply. |